By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

RedHill Biopharma Ltd. 

21 Ha’arba’a Street

Tel-Aviv    64739  Israel
Phone: 972-0-3-541-3131 Fax: 972-0-3-541-3144


SEARCH JOBS


Industry
Pharmaceutical






Company News
RedHill Biopharma (RDHL) Announces National Cancer Institute Grant Supporting YELIVATM Phase II Hepatocellular Carcinoma Study 5/17/2016 9:42:52 AM
RedHill Biopharma (RDHL) Announces National Cancer Institute Grant Supporting YELIVA Phase II Hepatocellular Carcinoma Study 5/5/2016 9:11:03 AM
RedHill Biopharma (RDHL) Reports 2016 First Quarter Financial Results 5/2/2016 9:10:22 AM
RedHill Biopharma (RDHL) Announces Positive FDA Meeting On RHB-105 Path To Approval And Planned Confirmatory Phase III Study For H. Pylori Infection 4/18/2016 10:29:51 AM
RedHill Biopharma (RDHL) Initiates Phase II Study Of BEKINDA For Irritable Bowel Syndrome 4/12/2016 10:06:10 AM
RedHill Biopharma (RDHL) Announces Interim Results From Phase IIa Proof-Of-Concept Study Supporting Therapeutic Potential Of RHB-104 In Multiple Sclerosis 4/5/2016 9:16:03 AM
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce RIZAPORT Commercialization Term Sheet With Grupo JUSTE For Spain And Additional Potential Territories 4/4/2016 9:11:59 AM
RedHill Biopharma (RDHL) And IntelGenx Corp. Announce RIZAPORT Commercialization Term Sheet With Grupo JUSTE For Spain And Additional Potential Territories 3/30/2016 9:07:42 AM
RedHill Biopharma (RDHL) Reports Successful Final Results Of Phase III Study With RHB-105 For H. pylori Infection 3/10/2016 9:01:19 AM
RedHill Biopharma (RDHL) Announces Peer-Reviewed Publication Demonstrating Therapeutic Potential Of YELIVA In Cholangiocarcinoma Cancer 3/10/2016 8:05:48 AM
12345678910...
//-->